I'm curious about this branching of research like this into liver and biliary tract diseases. The article says

>They teamed up with scientists in Germany to investigate the role of IL-11, which is known to trigger scarring in other organs, including the liver, lungs and heart, in acute and chronic kidney disease

I have sclerosing cholangitis, I wonder if I'll see a drug trial soon about this for PSC patients.